Cargando…
Thymic stromal lymphopoietin and alarmins as possible therapeutical targets for asthma
Overview of epithelial cytokines, particularly thymic stromal lymphopoietin (TSLP), released by the airway epithelium and the effects of their inhibition on the outcomes of patients with asthma. RECENT FINDINGS: The epithelial cytokines are early mediators at the top of the inflammatory cascade and...
Autores principales: | Salvati, Lorenzo, Maggi, Laura, Annunziato, Francesco, Cosmi, Lorenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722372/ https://www.ncbi.nlm.nih.gov/pubmed/34608100 http://dx.doi.org/10.1097/ACI.0000000000000793 |
Ejemplares similares
-
New approaches to transcutaneous immunotherapy: targeting dendritic cells with novel allergen conjugates
por: Weiss, Richard, et al.
Publicado: (2013) -
MicroCrystalline Tyrosine-adsorbed immunotherapy
por: Al Saleh, Helal, et al.
Publicado: (2022) -
S100A alarmins and thymic stromal lymphopoietin (TSLP) regulation in severe asthma following bronchial thermoplasty
por: Gagnon, Pierre-Alexandre, et al.
Publicado: (2023) -
Expression and Regulation of Thymic Stromal Lymphopoietin and Thymic Stromal Lymphopoietin Receptor Heterocomplex in the Innate–Adaptive Immunity of Pediatric Asthma
por: Lin, Sheng-Chieh, et al.
Publicado: (2018) -
Signal transduction around thymic stromal lymphopoietin (TSLP) in atopic asthma
por: Sebastian, Katrin, et al.
Publicado: (2008)